In vitro microsomal metabolism of hydrazine

References

• Blair I. A., Mansilla Tinoca R., Brodie M. J., Clare R. A., Dollery C. T., Timbrell J. A., Beever I. A. Plasma hydrazine concentrations in man after isoniazid and hydralazine administration. Human Toxicology 1985; 4: 195–202
   PubMedGoogle Scholar
• Burke M. D., Thompson S., Elcombe C. R., Halpert J., Haaparanta T., Mayer R. T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochemical Pharmacology 1985; 34: 3337–3345
   PubMed Web of Science ®Google Scholar
• Cain K., Skilleter D. N. Preparation and use of mitochondria in toxicological research. Biochemical Toxicology, A Practical Approach, K. Snell, B. Mullock. IRL, Oxford 1987; 217–252
   Google Scholar
• Coomes M. W., Prough R. A. The mitochondrial metabolism of 1,2-disubstituted hydrazines, procarbazine and 1,2-dimethylhydrazine. Drug Metabolism and Disposition 1983; 11(6)550–555
   PubMed Web of Science ®Google Scholar
• Gold J. Hydrazine sulphate: a current perspective. Nutrition in Cancer 1987; 9(2/3)59–66
   PubMedGoogle Scholar
• Hines R. N., Prough R. A. The characterization of an inhibitory complex formed with cytochrome P450 and a metabolite of 1,1-disubstituted hydrazines. Journal of Pharmacology and Experimental Therapeutics 1980; 214: 80–86
   PubMed Web of Science ®Google Scholar
• Jenner A. M., Timbrell J. A. Hydrazine metabolism in rat liver microsomes. Human and Experimental Toxicology 1990; 9: 335–336
   Google Scholar
• Jenner A. M., Timbrell J. A. Influence of inducers and inhibitors of cytochrome P450 on the hepatotoxicity of hydrazine in vivo. Archives of Toxicology 1994; 68: 349–357
   PubMed Web of Science ®Google Scholar
• Kimball R. F. The mutagenicity of hydrazine and some of its derivatives. Mutation Research 1977; 39: 111–126
   PubMed Web of Science ®Google Scholar
• Koop D. R. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cyt P-450 isozyme 3a. Molecular Pharmacolology 1986; 29: 339–404
   Web of Science ®Google Scholar
• Lake B. G. Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism. Biochemical Toxicology, A Practical Approach, K. Snell, B. Mullock. IRL, Oxford 1987; 183–213
   Google Scholar
• Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin-phenol reagent. Journal of Biological Chemistry 1951; 193: 265–275
   PubMed Web of Science ®Google Scholar
• Markosyan K. A., Paityan N. A., Nalbandyan R. M. Influence of hydrazine on properties of cytochrome oxidase. Biokhimiya (transl) 1988; 53(7)1136–1143
   PubMed Web of Science ®Google Scholar
• Moloney S. J., Prough R. A. Biochemical toxicology of hydrazines. Reviews in Biochemical Toxicology 1983; 5: 313–346
   Google Scholar
• Nelson S. D., Gordon W. P. Metabolic activation of hydrazines. Biological Reactive Intermediates Ii, Part B: Chemical Mechanisms and Biological Effects, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, G. G. Gibson, C. M. Witmer. Plenum, New York 1982; 971–981
   Google Scholar
• Nelson S. D., Mitchell J. R., Timbrell J. A., Snodgrass W. R., Corcoran G. B. Isoniazid and iproniazid: activation of metabolites to toxic intermediates in man and rat. Science 1976; 193: 901–903
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Mitchell J. R., Snodgrass W. R., Timbrell J. A. Hepatotoxicity and metabolism of iproniazid and isopropylhydrazine. Journal of Pharmacology and Experimental Therapeutics 1978; 206: 574–585
   PubMed Web of Science ®Google Scholar
• Noda H., Eto S., Minemoto M., Noda A., Ohno K. Effects of isoniazid and its metabolites on phenytoin biotransformation in isolated rat hepatocytes. Chemical Pharmaceutical Bulletins 1987a; 35(1)277–281
   PubMed Web of Science ®Google Scholar
• Noda A., Noda H., Misaka A., Sumimoto H., Tatsumi K. Hydrazine radical formation catalysed by rat microsomal NADPH cytochrome P450 reductase. Biochemical and Biophysical Research Communications 1988; 153: 256–260
   PubMed Web of Science ®Google Scholar
• Noda A., Noda H., Ohno K., Sendo T., Misaka A., Kanazawa Y., Isobe R., Hirata M. Spin trapping of a free radical intermediate formed during microsomal metabolism of hydrazine. Biochemical and Biophysical Research Communications 1985; 133(3)1086–1091
   PubMed Web of Science ®Google Scholar
• Noda A., Sendo T., Ohno K., Noda H., Goto S. Metabolism and cytotoxicity of hydrazine in isolated rat hepatocytes. Chemical Pharmaceutical Bulletins 1987b; 35(6)2538–2544
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Ohyama Y., Masumoto O., Usin E., Ukuda K. Multi-functional property of rat liver mitochondrial cytochrome P-450. Journal of Biochemistry 1991; 109: 389–393
   PubMed Web of Science ®Google Scholar
• Preece N. E., Ghatineh S., Timbrell J. A. Studies on the disposition and metabolism of hydrazine in rats in vivo. Human and Experimental Toxicology 1992; 11(2)121–127
   PubMed Web of Science ®Google Scholar
• Prough R. A. The N-oxidation of alkylhydrazines catalysed by the microsomal mixed function amine oxidase. Archives of Biochemistry and Biophysics 1973; 158: 442–444
   PubMed Web of Science ®Google Scholar
• Prough R. A., Freeman P. C., Hines R. N. The oxidation of hydrazine derivatives catalysed by the purified liver microsomal FAD-containing monooxygenase. Journal of Biological Chemistry 1981; 256: 4178–4184
   PubMed Web of Science ®Google Scholar
• Reinke L. A., Moyer M. J. p-Nitrophenol hydroxylation: a microsomal oxidation which is highly inducible by ethanol. Drug Metabolism and Disposition 1985; 13(5)548–552
   PubMed Web of Science ®Google Scholar
• Reynolds B. A., Thomas A. A. A colorimetric method for the determination of hydrazine and monomethylhydrazine in blood. American Industrial Hygiene Journal 1965; 26(4)527–530
   PubMedGoogle Scholar
• Sesardic D., Boobis A. R., Murray B. P., Murray S., Segura J., De la Torre R., Davies D. S. Furafylline is a potent and selective inhibitor of P450IA2 in man. British Journal of Clinical Pharmacology 1990; 29: 651–663
   PubMed Web of Science ®Google Scholar
• Spearman M. E., Moloney S. J., Prough R. A. Effect of cytosolic components on the metabolism of the hydrazide iproniazid. Molecular Pharmacology 1984; 26: 566–573
   PubMed Web of Science ®Google Scholar
• Steinhoff D., Mohr U., Schmidt W. M. On the question of carcinogenic action of hydrazine—evaluation on the basis of new experimental results. Experimental Pathology 1990; 39: 1–9
   PubMedGoogle Scholar
• Timbrell J. A., Harland S. J. Identification and quantification of hydrazine in the urine of patients treated with hydralazine. Clinical Pharmacology and Therapeutics 1979; 26: 81–88
   PubMed Web of Science ®Google Scholar
• Timbrell J. A., Scales M. D., Streeter A. J. Studies on hydrazine hepatotoxicity. 2. Biochemical findings. Journal of Toxicology and Environmental Health 1982; 10: 955–968
   PubMed Web of Science ®Google Scholar
• Witkop J. A., Prough R. A., Reed D. J. Oxidative demethylation of N-methylhydrazines by rat liver microsomes. Archives of Biochemistry and Biophysics 1969; 134: 308–315
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolism Reviews 1988; 19(1)1–32
   PubMed Web of Science ®Google Scholar